"You're doing an excellent job." Professor Dame Sally Davies, the UK's special envoy on antimicrobial resistance, has praised the RBA Initiative

Prof.Dame Sally Davies, the UK AMR Envoy and former Chief Medical Officer of England, invited Erick Venant, the founder and chief executive officer, to meet in person after a virtual encounter.
When Dame Sally and Venant met in Cambridge, UK, they discussed how we can all help to contain antimicrobial resistance (AMR). Dame Sally praised the RBA Initiative for its continuous efforts to combat AMR through engaging the younger generation and communities in Tanzania. (https://twitter.com/UKAMREnvoy/status/1468231832705675274?t=lLyRq4SyKgEXBz3SgWGzJA&s=03).
The CEO of the RBA Initiative, for his part, praised Dame Sally for her hard efforts to raise awareness about AMR on a global scale.

About Professor Dame Sally Davies
Professor Dame Sally is the Special Envoy on Antimicrobial Resistance for the United Kingdom and a member of the Global UN leaders’ group on antimicrobial resistance. Previously, Dame Sally was Chief Medical Officer for England and Chief Medical Adviser to the UK Government (2011-2019). In this role, she founded the National Institute for Health Research and served on the World Health Organization Executive Board. Dame Sally has brought AMR to the forefront of the global health dialogue, including as a co-convener of the UN Interagency Coordination Group on AMR. She brought together experts and leaders from different regions, sectors, and disciplines to recommend actions to accelerate global action on AMR. Dame Sally was elected Fellow of the Royal Society in 2014 and a member of the National Academy of Medicine, the USA in 2015. In the 2020 New Year Honors, Dame Sally became the second woman (and the first outside the Royal Family) to be appointed Dame Grand Cross of the Order of the Bath (GCB) for services to public health and research.

Watch this powerful presentation by her on the tragedy of reliance on antimicrobials, which are becoming more and more ineffective against relatively common, yet life-threatening diseases such as TB, HIV/AIDS, Malaria, Pneumonia, and Urinary Tract Infections. https://www.youtube.com/watch?v=7evvWt8XN7o

Get Our Newsletter